Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family Ajellomycetaceae

Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01886-17. doi: 10.1128/AAC.01886-17. Print 2018 Jan.

Abstract

The in vitro susceptibilities of 24 molecularly identified dimorphic fungi belonging to the genera Adiaspiromyces, Blastomyces, and Emergomyces within the family Ajellomycetaceae were tested against 8 standard antifungal agents using CLSI document M38-A2. Amphotericin B and posaconazole had the lowest geometric mean MICs (<0.05 μg/ml) followed by itraconazole (<0.07 μg/ml), voriconazole (<0.15 μg/ml), and isavuconazole (<0.42 μg/ml) while fluconazole was not active. Micafungin demonstrated good in vitro antifungal activity against Emergomyces (geometric mean minimum effective concentration [GM MEC] 0.1 μg/ml) and Blastomyces (GM MEC <0.017 μg/ml).

Keywords: Adiaspiromyces; Blastomyces; CLSI; Emergomyces; antifungal susceptibility testing; dimorphic fungi.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Fungi / drug effects*
  • Humans
  • Microbial Sensitivity Tests / methods
  • Rodentia / microbiology
  • Soil
  • Soil Microbiology

Substances

  • Antifungal Agents
  • Soil